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TrypanosomeHP and HPR are related and contiguous genes in strong linkage disequilibrium (LD), encoding haptoglobin
and haptoglobin-related protein. These bind and chaperone free Hb for recycling, protecting against oxida-
tion. A copy number variation (CNV) within HP (Hp1/Hp2) results in different possible haptoglobin com-
plexes which have differing properties. HPR rs2000999 (G/A), identiﬁed in meta-GWAS, inﬂuences total
cholesterol (TC) and LDL-cholesterol (LDL-C). We examined the relationship between HP CNV, HPR
rs2000999, Hb, red cell count (RCC), LDL-C and TC in the British Women's Heart and Health Study
(n=2779 for samples having CNV, rs2000999, and phenotypes). Analysing single markers by linear regres-
sion, rs2000999 was associated with LDL-C (β=0.040 mmol/L, p=0.023), TC (β=−0.040 mmol/L,
p=0.019), Hb (β=−0.044 g/dL, p=0.028) and borderline with RCC (β=−0.032×1012/L, p=0.066).
Analysis of CNV by linear regression revealed an association with Hb (Hp1 vs Hp2, β=0.057 g/dL, p=0.004),
RCC (β=0.045×1012/L, p=0.014), and showed a trend with LDL-C and TC. There were 3 principal haplotypes
(Hp1-G 36%; Hp2-G 45%; Hp2-A 18%). Haplotype comparisons showed that LDL-C and TC associations were
from rs2000999; Hb and RCC associations derived largely from the CNV. Distinct genotype–phenotype effects
are evident at the genetic epidemiological level once LD has been analysed, perhaps reﬂectingHP–HPR function-
al biology and evolutionary history. The derived Hp2 allele of the HP gene has apparently been subject to
malaria-driven positive selection. Haptoglobin-related protein binds Hb and apolipoprotein-L, i.e. linking HPR
to the cholesterol system; and the HPR/apo-L complex is speciﬁcally trypanolytic. Our analysis illustrates
the complex interplay between functions and haplotypes of adjacent genes, environmental context and natural
selection, and offers insights into potential use of haptoglobin or haptoglobin-related protein as therapeutic
agents.
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 license. 1. Introduction
The haptoglobin gene exists in the human population in two
forms: Hp1 and Hp2. Hp1 is the less frequent allele in Europeans.
Exons 5 and 6 of Hp2 represent duplication of a 1.7 kb segment con-
taining exons 3 and 4 of Hp1. The protein product of Hp1,1 is a dimer,
whereas the products of Hp1,2 or Hp2,2 are multimers of respectively
increasing complexity which have reduced availability to tissues. The
function of haptoglobin, which is normally present at greater than a
400-fold molar excess compared with free Hb is to scavenge free Hb
which has been liberated into the plasma by intravascular haemoly-
sis. The haptoglobin/Hb complex is cleared from the bloodstream by
circulating monocytes or in the liver by Kuppfer cells, and the heme
iron is recycled; at sites of tissue damage, the complex is cleared by
macrophages. The range of possible forms of haptoglobin, from
dimer to large multimer depending on genotype, results in a gene
product with a range of properties and potentially complex interac-
tions. For example, although the Hb-binding capacity of Hp2,2 is
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binds to CD163 (the haptoglobin receptor expressed on macrophage
and monocyte cell surfaces) with a 10-fold higher afﬁnity than the
Hp1,1–Hb complex (Kristiansen et al., 2001).
There is evidence that the duplication has been shown to be under
positive selection in areas where malaria is endemic, with the Hp2,2
genotype being protective (Quaye et al., 2000). Some studies have
failed to ﬁnd protection associated with the Hp2 allele (Bienzle et al.,
2005) but this discrepancy may be due to haplotypic association be-
tween Hp2 and a haptoglobin promoter SNP present at differing fre-
quencies in the populations studied (Cox et al., 2007). The Hp2
protective effect is likely to have many components, including in-
creased secretion of anti-inﬂammatory cytokines due to binding of
the Hp2,2/Hb complex to the macrophage CD163 receptor (Moestrup
and Moller, 2004). The results of association studies between HP CNV
and LDL-C level have been equivocal (Delanghe et al., 1993;
Delanghe et al., 1997; Saha et al., 1992). However, a recent meta-
GWAS study (Teslovich et al., 2010) identiﬁed a SNP (rs2000999) in
the HPR gene as marking one of 95 loci inﬂuencing lipid levels, and a
GWAS study (Igl et al., 2010) identiﬁed an association of the same
SNP with serum cholesterol levels. We therefore typed both the
HP CNV and the HPR rs2000999 (D′ −0.91, r2 0.11) in a cohort study
(including one with GWAS data available) to test the genotypic asso-
ciation between both genetic variants and LDL-C level. In addition,
because of haptoglobin's primary function as a scavenger of free Hb,
we set out to test whether there was an association between each
polymorphism and Hb concentration, and between each polymor-
phism and RCC. Haplotypes comprised of HP CNV and HPR rs2000999
were also constructed and tested in relation to all three traits.
2. Materials and methods
2.1. HP CNV data acquisition
We typed the HP CNV in the British Women's Heart and Health
Study (BWHHS) (Lawlor et al., 2003), a cohort that originally
recruited 4286 women from 23 British towns, aged between 60 and
79 years at enrolment (1999–2001) At baseline assessment the
women completed a questionnaire, a nurse-led health interview
and a physical examination at which fasting blood samples
(requested to fast for a minimum of 8 h) were taken. DNA was
extracted from K-EDTA whole blood from 3884 individuals using a
salting-out procedure (Miller et al., 1988), and this was analysed
using Ampliﬁcation Ratio Control System (ARCS), a ratiometry-
preserving PCR protocol (Guthrie et al., 2011). Brieﬂy, ARCS compares
target gene copy number against a single-copy reference gene by am-
plifying both target and reference using a single universal primer for
both ends of both amplicon species, after two initial sequence-speciﬁc
PCR priming cycles. Ampliﬁcation with a single universal primer min-
imises differences in ampliﬁcation kinetics between target and refer-
ence amplicons and ensures the preservation of accurate ratiometry
throughout PCR. Numbers of each genotype were obtained as follows:
absence of a peak for the HP amplicon/presence of a peak for the TP53
amplicon was classiﬁed as Hp1,1; Hp1,2 and Hp2,2 were classiﬁed
according to their within-cluster positions in scatter plots of ﬂuores-
cence intensity for HP amplicon vs TP53 amplicon, and in scatter
plots of HP/TP53 peak height ratio vs the square root of the sum of
the squares of both peaks. Data from DNA which failed to amplify,
or whose amplicons ﬂuoresced at an intensity below a minimum
threshold, were discarded.
2.2. HPR SNP data acquisition
HPR rs2000999 association data were obtained for the same co-
hort using the CardioChip 50K SNP genotyping array (Keating et al.,
2008), a chip containing 48,000 SNP markers for over 2000 genesassociated with cardiovascular disease. Genotyping was successfully
performed on 3445 of these samples, and after applying ﬁltering
limits for cluster separation (b0.3), call frequency (b0.95), mean nor-
malised intensity of the heterozygote cluster (b0.3), mean of the nor-
malised theta values of the heterozygote cluster (b0.2 or >0.8), and
heterozygote excess (b−0.3 or >0.1), this number was reduced to
3413 (Zabaneh et al., 2011).
2.3. Phenotype data acquisition
Haemoglobin and RCC were assayed in local haematology depart-
ments in each of the towns within 24 h of the blood being taken,
using the standard Coulter counter method on EDTA blood. TC, HDL-
C and triglycerides were measured on frozen serum samples using
an Hitachi 747 analyser (Roche Diagnostics) and standard reagents.
LDL-C was calculated from the Friedewald equation: LDL-C=TC−
(HDL-C+triglycerides×0.45) (Friedewald et al., 1972).
2.4. Cohort numbers for CNV and SNP
Of the 4286 participants, 3125 (72.9%) had a valid HP CNV geno-
type and 3436 (80.2%) had valid HPR rs2000999 data. Of the 3125
with HP CNV, 2887 had complete data on all phenotypes and of the
3436 with HPR rs2000999, 3208 had complete data on all phenotypes.
Thus, our analyses are conducted on 3125 women when examining
associations of HP CNV with phenotypes and 3208 women when ex-
amining associations of HPR rs2000999 with phenotypes. For analyses
with haplotypes we have 2779 women.
2.5. Statistical analyses
Deviations from Hardy–Weinberg proportions were tested for
each marker, using the HW equilibrium calculator (http://www.
oege.org/software/hwe-mr-calc.shtml) as previously described
(Rodriguez et al., 2009). Analysing single markers, we performed as-
sociation tests between HP CNV/LDL-C and TC levels, and between HP
CNV/Hb-related phenotypes (Table 1). Similar analyses were per-
formed for HPR rs2000999, with the a priori hypothesis that there
would be association between both genetic variants and LDL-C, TC,
Hb and RCC. Since small allelic effects in complex traits tend to be ap-
proximately additive and there is no compelling basis to posit another
genetic model for haptoglobin (consider for example Teslovich et al.,
2010), linear regression was used to test for association between each
phenotype and each genetic marker, using PASW Statistics 18. Haplo-
typic analyses were conducted using Haplotype Trend Regression
(HTR). HTR estimates the haplotype frequencies by use of the expec-
tation–maximization (EM) algorithm and then relates the inferred
haplotype frequencies to the observed phenotype using a regression
model (Zaykin et al., 2002). The approach gives a signiﬁcance value
(deduced by an F test) and a mean trait value for each haplotype in
relation to each trait.
Conﬁdence intervals for phenotypic mean values observed for
each haplotype were computed using PASW Statistics 18 from phased
haplotypes. Phased haplotypes were derived from PLINK using the
command ‘plink–ﬁle mydata–hap myﬁle.hlist–hap-phase’ (Purcell et
al., 2007).
Individual level data are subject to data security regulations, but
can be provided to any bona ﬁde researcher upon request to the
BWHHS committee.
3. Results
3.1. HP CNV and HPR SNP genotype associations
Allele frequencies for HP CNV and HPR rs2000999 were in Hardy
Weinberg equilibrium (HP CNV χ2=0.32, p=0.572; HPR
Table 1
Mean levels for LDL-C, TC, Hb and RCC, by HP CNV and HPR rs2000999 genotype.
Genotype counts LDL-C
(mmol/L) [SD]
TC
(mmol/L) [SD]
Hb conc
(g/dL) [SD]
RCC
(×1012/L) [SD]
HP CNV 2887
Hp 1,1 394 4.06 [1.05] 6.60 [1.29] 13.46 [1.02] 4.58 [0.39]
Hp 1,2 1326 4.14 [1.08] 6.61 [1.18] 13.49 [1.13] 4.57 [0.39]
Hp 2,2 1167 4.17 [1.12] 6.67 [1.21] 13.62 [1.01] 4.61 [0.37]
p valuea 0.225 0.112 0.004 0.014
HPR rs2000999 3208
GG 2127 4.12 [1.10] 6.61 [1.23] 13.47 [1.13] 4.57 [0.40]
AG 962 4.20 [1.06] 6.71 [1.19] 13.56 [1.05] 4.59 [0.37]
AA 119 4.25 [1.05] 6.72 [1.09] 13.62 [0.99] 4.64 [0.36]
p valuea 0.023 0.019 0.028 0.066
RCC R2=0.1%. All other phenotypes R2=0.2%.
a p value from linear regression with 1 df.
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CNV and HPR rs2000999 with each phenotype. There was no strong
statistical evidence of an association between HP CNV and LDL-C or
TC levels, but there was evidence of association with Hb concentra-
tion (p=0.004) and RCC (p=0.014); Hp2,2 was associated with
the highest Hb concentration and the highest RCC and levels of each
phenotype were similar in Hp1,1 and Hp1,2 participants. There was
statistical evidence of associations between HPR rs2000999 and
LDL-C and TC (p=0.023, p=0.019 respectively); individuals with
either AG or AA had similar levels that were higher than those with
GG. rs2000999 also showed association with Hb concentration
(p=0.028); AA was associated with the highest concentration, GG
with the lowest and AG intermediate. A trend in the same directionTable 2
Estimated mean levels for LDL-C, TC, Hb, and RCC-haplotype frequencies, conﬁdence
intervals and p-values.
Haplotype
HP CNV
allele
HPR
rs2000999
allele
Estimated
haplotype
frequencies a
Mean LDL-C
(mmol/L) b
Conﬁdence
interval c
p-value d
Hp1 A 0.0063 3.92 3.37, 4.47 0.570
Hp1 G 0.3621 4.11 4.06, 4.16 0.138
Hp2 A 0.1840 4.22 4.15, 4.29 0.011
Hp2 G 0.4475 4.13 4.09, 4.18 0.632
Mean TC
(mmol/L)
Hp1 A 0.0063 6.32 5.82, 6.82 0.428
Hp1 G 0.3621 6.61 6.55, 6.66 0.132
Hp2 A 0.1840 6.72 6.64, 6.79 0.015
Hp2 G 0.4475 6.62 6.57, 6.67 0.717
Mean Hb
(g/dL)
Hp1 A 0.0063 13.53 13.00, 14.05 0.997
Hp1 G 0.3612 13.46 13.41, 13.51 0.001
Hp2 A 0.1835 13.60 13.53, 13.66 0.019
Hp2 G 0.4489 13.55 13.50, 13.59 0.162
Mean RCC
(×1012/L)
Hp1 A 0.0063 4.56 4.42, 4.70 0.731
Hp1 G 0.3612 4.57 4.55, 4.59 0.010
Hp2 A 0.1835 4.61 4.58, 4.63 0.073
Hp2 G 0.4489 4.59 4.58, 4.61 0.254
a Estimated haplotype frequencies, derived using expectation maximization algo-
rithm with haplotype trend regression (HTR).
b Mean trait value for each haplotype, derived using HTR.
c 95% CI for each trait value from phased haplotypes.
d p-value for association between haplotype and trait value, derived using HTR.was visible with RCC, though the association failed to reach conven-
tional levels of 5% statistical signiﬁcance (p=0.066). The ancestral
HP non-duplicon allele and ancestral HPR rs2000999 genotype GG
are both associated with the lowest Hb concentration, together ac-
counting for ~0.5% of Hb variance. Similar results were obtained
(Supplementary Table 1) when these analyses were repeated consid-
ering only those individuals with genotypic data for both markers
(n=2779); in this analysis, power using 2779 participants ranged
from ~50% to ~90%.
3.2. Haplotype associations
Of the two locus haplotypes comprised of HP CNV and HPR
rs2000999, one, Hp1-A, occurred at very low frequency (0.6%). The
three principal haplotypes are: Hp1-G 36%; Hp2-G 45%; Hp2-A 18%.
In Table 2, analysis of haplotypes for LDL-C and TC shows that the
Hp2-A haplotype raises the levels of both, the associations derived
predominantly from the HPR rs2000999 “A” allele (LDL-C
β=0.037 mmol/L, p=0.011; TC β=0.036 mmol/L, p=0.015). Analysis
of haplotypes for Hb concentration and RCC shows that the Hp1-G hap-
lotype is associated with lower levels of both, the associations derived
mainly from the ancestral HP non-duplicon (Hb β=0.039 g/dL,
p=0.001; RCC β=0.031×1012/L, p=0.010). Table 3, summarising
phenotype p-values for different combinations of haplotype compari-
son, provides strong statistical evidence for cholesterol (TC and LDL-C)
level associations with Hp2-G vs Hp2-A, and for Hb-based (Hb level
and RCC) associations with Hp1-G vs Hp2-G.
4. Discussion
Composite analysis of two known important genetic variants in
HP–HPR conﬁrmed an association of the region with serum TC and
LDL-C. Also, not previously known, we showed an association be-
tween these genetic variants and blood Hb and RCC. We present hap-
lotype data enabling inference of historical order of mutation of theseTable 3
p-values of inter-haplotype comparisons for mean LDL-C, TC, Hb, and RCC.
Haplotype
interaction
LDLC (mmol/L)
p-valuea
TC (mmol/L)
p-value
Hb conc (g/dL)
p-value
RCC (×1012/L)
p-value
Hp2-G vs
Hp2-A
0.033 0.036 0.192 0.321
Hp1-G vs
Hp2-G
0.551 0.708 0.041 0.010
Hp1-G vs
Hp2-A
0.009 0.021 0.011 0.001
a p value is generated by linear regression of haplotypes against each phenotype.
Fig. 2. Schematic of haplotype/phenotype interactions. Putative malaria-induced se-
lection pressure has caused an increase in Hb and RCC levels for the Hp1-G to Hp2-
G duplication. The inferred Hp2-A derivation from Hp2-G is associated with raised
TC and LDL-C levels, possibly reﬂecting interaction of HPR with the lipoprotein
system.
11P.A.I. Guthrie et al. / Gene 499 (2012) 8–13variants (Fig. 1), and enabling inference about mechanisms of causal-
ity between the different haplotypes and different phenotypes
(Fig. 2).
It is thought that the HP–HPR gene duplication occurred at least
30 Ma ago (Maeda and Smithies, 1986), with the HPR gene, which
lies ~2.2 kb 3′ to HP, arising by non-homologous breakage and re-
union. Fig. 1 shows the inferred human evolutionary history of the
HP CNV and HPR SNP variants based on our haplotype analyses.
Since there are effectively only three haplotypes, there are two clad-
ograms to consider (Fig. 1 panels A and B). However, if the A/G mu-
tation predated the 1/2 mutation, then a G-1 allele would have had
to be formed from a G-2 allele, whereas this is obviously implausi-
ble because the non-duplicon allele almost certainly predated the
duplicon allele. Therefore Fig. 1A represents the human history of
order of these mutations. For markers which are in very close ge-
netic linkage, as these are, it is usual for three haplotypes to be
formed (i.e. D′=1) and for the fourth only to form later and slowly
by recombination events. If A-1 were among the ancestral three
haplotypes, then in addition to having rapid recombination to
form the fourth haplotype, selection would also have had to elimi-
nate almost entirely, the A-1 allele. Again, therefore, Fig. 1A appears
to be the most parsimonious with the data and to represent the
likely history.
The relationships between haplotypes and phenotypes are sum-
marised in Fig. 2, in which it can be seen that the HP CNV is associated
with, and plausibly causal of, effects on Hb and RCC, whereas the cho-
lesterol association relates to HPR rs2000999. Known (Atkinson et al.,
2007; Quaye et al., 2000) selection pressure (putatively malaria-
induced) on haplotypes can be seen to have occurred in conjunction
with the occurrence of a haplotype resulting in an increase in Hb
and RCC levels. It is plausible that survival in malaria would involve
avoidance of extreme anaemia, which even with a small effect such
as 0.1 g/dL could give rise to signiﬁcant selection over a period as
short as 2000 years (100 generations). Alternatively, previously
reported (Na et al., 2005) anti-oxidation effects of the Hp2 allele
may be relevant.
The HPR gene is expressed at a level b10% to that to HP (Muranjan
et al., 1998; Nielsen et al., 2006), and hence would be expected to
exert little effect on Hb levels compared with HP. Most of the product
of HPR is associated with trypanosome lytic factors TLF-1 and TLF-2,
both of which contain ApoL-I and ApoA-I. TLF-1 and -2 are both capa-
ble of lysing the protozoan parasite Trypanosoma brucei (Nielsen
and Moestrup, 2009) which causes sleeping sickness in nonprimate
mammals, with the HPR product acting as a ligand for, and thus guid-
ing the lytic complex to, the parasite surface. HPR is therefore linkedFig. 1. Deduced human evolution for haplotypes of HP CNV (alleles 1 and 2) with HPR
rs200999 (alleles A and G). The frequency of haplotype Hp1-A is extremely low, result-
ing in effectively three remaining haplotypes. Two cladograms can therefore be consid-
ered: panel ‘A’ is the plausible evolutionary route for the emergence of haplotype Hp2-
A; panel ‘B’ is difﬁcult to rationalise with the known genomic biology route, since this
model requires the non-duplicon Hp1-G haplotype to have arisen from the duplicon
haplotype Hp2-G.via TLF-I (containing apoA-I, apoA-II, and apoL-I) to the cholesterol
system, thus providing a functional explanation for the HPR SNP asso-
ciation. While it is as yet unknownwhether HPR rs2000999 G/A inﬂu-
ences apoL-1 and trypanosome levels, it is known that apoL-1 level is
associated with TC (but not HDL-C) and with primary hypercholester-
olemia (Duchateau et al., 2000), further supporting the genetic epide-
miological evidence pointing to a speciﬁc interaction between HPR
and lipoproteins. However, it remains possible that rs2000999 may
proxy a causal variation not in HPR, but in HP (though not the CNV)
or some other neighbouring gene.
The associations we observe between haptoglobin genotype and
Hb and RCC ﬁt with known functional biology. Haptoglobin is the
principal binding protein for free Hb. Hp2 is associated with a
higher Hb and RCC. A previous report showed serum free Hb to
be approximately 0.01 g/dL higher in a group of Hp1,1 genotype
(Na et al., 2005). This was suggested to reﬂect the known higher af-
ﬁnity of Hp2,2 for the CD163 receptor on macrophages. Our obser-
vation of more than 0.1 g/dL greater Hb in Hp2,2, and a higher
RCC, suggests in addition a more efﬁcient recycling process for com-
ponents of Hb. In any protozoal or parasitic disease causing respec-
tively haemolysis or blood loss, the Hp2 allele would offer a
selective advantage, in addition to the reduction of oxidation dam-
age during haemolysis.
Concerning the genetic model (additive, dominant, recessive or
intermediate), we used regression tests consistent with the hypothe-
sis of small additive allelic effects typical of complex traits. For HP
CNV, haptoglobin complexes are largest for Hp2,2, dimers for Hp1,1
and intermediate for Hp1,2. However, the directions of effect on
other phenotypes would be difﬁcult to predict from these data
alone. For HPR rs2000999, there was a prior hypothesis of direction
of effect on TC and LDL-C from Teslovich et al. (2010). However, our
regression statistic did not incorporate this, although we infer addi-
tional signiﬁcance noting that the allelic direction of effect is the
same in our study as in Teslovich et al. (2010). The sample is not
large enough to give the statistical power to test the deviation from
the additive model across each trait for each genotype. For LDL-C
with HPR rs2000999, there appears to be a linear pattern across geno-
types but less so across CNV genotypes for Hb. It is possible that HP
CNV may confer nonlinear effects considering that molecular weights
have been estimated at ~86 kD for genotype Hp1,1; ~90 to 300 kD for
genotype Hp1,2, and ~170 to 900 kD for Hp2,2 (Sadrzadeh and
Bozorgmehr, 2004).
From haplotype analysis, it is evident that the cholesterol effects
are derived from the HPR SNP. Previous reports (Braeckman et al.,
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lesterol association of the HP CNV appear to reﬂect the linkage dis-
equilibrium of the CNV with another feature in the HP–HPR
region, as yet best marked by the HPR rs2000999. By contrast, the
Hb and RCC associations, not previously known, reﬂect the HP
CNV, which may well be the causal site for that effect. The genetic
epidemiological observations appear to mirror the known function-
al biology, viz. that the product of HP is the principal interactor
with Hb, whereas the product of HPR exhibits speciﬁc interactions
with the lipoprotein system. These phenotypic effects are of inter-
est with respect to CHD risk, but historically the genetic and haplo-
type architecture has likely been driven by at least two protozoal
infections. The observed haplotypic associations illustrate the com-
plex interplay of genes in blocks of linkage disequilibrium, with dif-
ferent phenotypes relevant to complex traits such as coronary
disease. Since haptoglobin is a potential therapeutic product
which has been shown to decrease the hypertensive and oxidative
effects of Hb in dogs and guinea pigs (Boretti et al., 2009), the ge-
notypic ‘intervention’ may offer useful insight into the possible
spectrum of phenotypic changes that might be induced using puri-
ﬁed, genetically engineered or pharmacologically induced haptoglo-
bin or haptoglobin-related protein.
4.1. Study limitations
The variables chosen were selected from a large number of pheno-
types in BWHHS according to our prior hypothesis based on pub-
lished evidence for HPR, and we wanted to apply these results to
an analysis of the HP CNV. This was therefore an hypothesis-driven
selection and in this sense a certain bias cannot be ruled out, but it
is clear that a completely open, hypothesis-free screen is an excessive
task far beyond the scope of this study.
This study was conducted in a sample of older British women.
Cholesterol levels, Hb levels and RCC show age, sex and ancestry
differences; it is therefore possible that the observations in this
study might not generalise globally. Analyses were conducted on
72.9% and 80.2%, for HP CNV and HPR rs2000999 respectively, of
the original 4286 participants because of missing data. However,
it is extremely unlikely that this resulted in any selection bias as
participants would have been unaware of their genotype and the
genotypic effects on health in earlier life are unlikely to have
been large enough to cause survival or ascertainment bias
(Rodriguez et al., 2009). Our ﬁndings need further replication in
other studies.
5. Conclusions
Using haplotypes comprised of HP CNV and HPR rs2000999, we
performed association analyses of cholesterol- and haemogobin-
related phenotypes in a cohort of British women. We found evidence
of association between HP CNV and Hb levels/RCC (a novel ﬁnding),
and between HPR rs2000999 and LDL-C/TC. The HP CNV/Hb-related
associations are possibly derived from malaria-driven positive selec-
tion, mediated through the selective advantage of the Hp2 allele mit-
igating the deleterious effects of haemolysis and subsequent
oxidation damage. The cholesterol associations relate to HPR
rs2000999, likely through the interactions of the HPR product with
the lipoprotein system via the trypanosome lytic factors TLF-1 and
TLF-2, which contain ApoL-I and ApoA-I. We have inferred the evolu-
tionary history of the HP CNV and HPR SNP variants in humans, show-
ing that the HP CNV duplication event almost certainly preceded the
HPR SNP G/A mutation event. The haplotypic associations we have
observed demonstrate the potential complexity of gene interactions
within blocks of LD.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.gene.2012.03.034.Acknowledgments
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